Skip to main navigation Skip to search Skip to main content

Assay for drug discovery: Synthesis and testing of nitrocefin analogues for use as β-lactamase substrates

  • Ahmad Ghavami
  • , Geneviève Labbé
  • , Jürgen Brem
  • , Valerie J Goodfellow
  • , Laura Marrone
  • , Carol A Tanner
  • , Dustin T King
  • , Melinda Lam
  • , Natalie C J Strynadka
  • , Dylan R Pillai
  • , Stefan Siemann
  • , James Spencer
  • , Christopher J Schofield
  • , Gary I Dmitrienko

Research output: Contribution to journalArticle (Academic Journal)peer-review

22 Citations (Scopus)

Abstract

We report on the synthesis of three nitrocefin analogues and their evaluation as substrates for the detection of β-lactamase activity. These compounds are hydrolyzed by all four Ambler classes of β-lactamases. Kinetic parameters were determined with eight different β-lactamases, including VIM-2, NDM-1, KPC-2, and SPM-1. The compounds do not inhibit the growth of clinically important antibiotic-resistant gram-negative bacteria in vitro. These chromogenic compounds have a distinct absorbance spectrum and turn purple when hydrolyzed by β-lactamases. One of these compounds, UW154, is easier to synthesize from commercial starting materials than nitrocefin and should be significantly less expensive to produce.

Original languageEnglish
Pages (from-to)75-7
Number of pages3
JournalAnalytical Biochemistry
Volume486
DOIs
Publication statusPublished - 1 Oct 2015

Keywords

  • Biocatalysis
  • Cephalosporins
  • Chemistry Techniques, Synthetic
  • Drug Evaluation, Preclinical
  • Hydrolysis
  • Kinetics
  • beta-Lactamases

Fingerprint

Dive into the research topics of 'Assay for drug discovery: Synthesis and testing of nitrocefin analogues for use as β-lactamase substrates'. Together they form a unique fingerprint.

Cite this